RESEARCH COLLABORATION AND OPTION TO LICENSE AGREEMENT by and between 4D PHARMA PLC and MERCK SHARP & DOHME CORP.Research Collaboration and Option to License Agreement • January 8th, 2021 • 4D Pharma PLC • Pharmaceutical preparations • England and Wales
This Agreement (this “Agreement”) is effective as of October 7, 2019, (the “Effective Date”) and is entered into by and between 4D Pharma plc, having an address of 9 Bond Court, Leeds LS l 2JZ, United Kingdom (organized and existing under the laws of England and Wales (“Company”) and MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“MSD”).
RESEARCH COLLABORATION AND OPTION TO LICENSE AGREEMENT by and between SYNTHETIC GENOMICS, INC. and MERCK SHARP & DOHME CORP.Research Collaboration and Option to License Agreement • August 14th, 2019 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and Option to License Agreement (this “Agreement”) is effective as of May 22, 2017 (the “Effective Date”) and is entered into by and between SYNTHETIC GENOMICS, INC., a corporation organized and existing under the laws of Delaware (“Company”), and MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“Merck”).
